Opioids
Partnering to confront a crisis
Opioids represent a large class of medications commonly used to relieve acute and chronic pain or to help manage opioid abuse and dependence. These medications can produce physical and psychological dependence and have a high risk for abuse and diversion. As a result, many professional practice guidelines recommend compliance testing in patients who are prescribed these medications.
Opioid test menu
Targeted screening
Our targeted, high-resolution mass spectrometry screening assay does not hydrolyze the urine sample, allowing for both the parent and metabolites of 33 different opioids to be detected. Results of this assay enable clinicians to accurately detect opioid use and effectively monitor treatment compliance.
Key testing
- TOSU | Targeted Opioid Screen, Random, Urine
- Ensures adherence to federal and state regulations by:
- Monitoring compliance of patients prescribed opioids.
- Identifying potential illicit opioid use.
- Ensures adherence to federal and state regulations by:
Highlights
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.
Comprehensive monitoring
Several of our comprehensive profiles include targeted opioid screening (Mayo ID: TOPSU).
Panel testing
Key testing
- CSMEU | Controlled Substance Monitoring Enhanced Profile with Reflex, 21 Drug Classes, High Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
- CSMHU | Controlled Substance Monitoring Hybrid Drug Profile, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
- CSMTU | Controlled Substance Monitoring Targeted Profile, 17 Drug Classes, Mass Spectrometry, Random, Urine